{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:57:52Z","timestamp":1792108672737,"version":"4.4.0"},"reference-count":178,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. vasc. bras."],"abstract":"<jats:p>Abstract Deep vein thrombosis is one of the main causes of inpatient and outpatient morbidity, both in medical and surgical patients, significantly impacting mortality statistics and requiring prompt diagnosis so that treatment can be initiated immediately. This document was prepared and reviewed by 11 specialists certified by the Brazilian Society of Angiology and Vascular Surgery, who searched the main databases for the best evidence on the diagnostic (physical examination, imaging) and therapeutic approaches (heparin, coumarins, direct oral anticoagulants, fibrinolytics) to the disease.<\/jats:p>","DOI":"10.1590\/1677-5449.202301072","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T17:10:55Z","timestamp":1728493855000},"source":"Crossref","is-referenced-by-count":3,"title":["Guidelines on deep vein thrombosis of the Brazilian Society of Angiology and Vascular Surgery"],"prefix":"10.1590","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2271-5878","authenticated-orcid":false,"given":"Marcone Lima","family":"Sobreira","sequence":"first","affiliation":[{"name":"Universidade Estadual Paulista,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5329-7819","authenticated-orcid":false,"given":"Marcos \u00c1reas","family":"Marques","sequence":"additional","affiliation":[{"name":"Universidade do Estado do Rio de Janeiro,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6102-6923","authenticated-orcid":false,"given":"Adilson Ferraz","family":"Paschoa","sequence":"additional","affiliation":[{"name":"Associa\u00e7\u00e3o Portuguesa de Benefic\u00eancia de S\u00e3o Paulo,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6924-6602","authenticated-orcid":false,"given":"Alcides Jos\u00e9 Ara\u00fajo","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Hospital de Base do Distrito Federal,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1280-8352","authenticated-orcid":false,"given":"Ivan Benaduce","family":"Casella","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1124-0758","authenticated-orcid":false,"given":"Marcelo Calil","family":"Burihan","sequence":"additional","affiliation":[{"name":"Hospital Santa Marcelina,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4174-0315","authenticated-orcid":false,"given":"Marcelo Fernando","family":"Matielo","sequence":"additional","affiliation":[{"name":"Hospital do Servidor P\u00fablico Estadual de S\u00e3o Paulo,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7646-5208","authenticated-orcid":false,"given":"Rafael de Athayde","family":"Soares","sequence":"additional","affiliation":[{"name":"Hospital do Servidor P\u00fablico Estadual de S\u00e3o Paulo,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1537-0285","authenticated-orcid":false,"given":"Walter Junior Boin de","family":"Araujo","sequence":"additional","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brasil; Sociedade Brasileira de Angiologia e de Cirurgia Vascular,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7237-4771","authenticated-orcid":false,"given":"Edwaldo Edner","family":"Joviliano","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brasil; Sociedade Brasileira de Angiologia e de Cirurgia Vascular,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1504-8763","authenticated-orcid":false,"given":"Julio Cesar Peclat de","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Sociedade Brasileira de Angiologia e de Cirurgia Vascular,  Brasil; Universidade Federal do Estado do Rio de Janeiro,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2024]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"e351S","DOI":"10.1378\/chest.11-2299","article-title":"Diagnosis of DVT: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Bates SM","year":"2012","journal-title":"Chest"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1590\/S1677-54492012000200011","article-title":"Controv\u00e9rsias no diagn\u00f3stico e tratamento da trombose venosa profunda pela ecografia vascular controversies in the diagnosis and treatment of deep vein thrombosis for vascular ultrasound","volume":"11","author":"Barros MVL","year":"2012","journal-title":"J Vasc Bras"},{"key":"ref3","first-page":"1","article-title":"Thromboembolism","volume":"2011","author":"McManus RJ","year":"2010","journal-title":"Clin. Evid"},{"issue":"7","key":"ref4","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005674","article-title":"Shorter or longer anticoagulation to prevent recurrent venous thromboembolism: systematic review and meta-analysis","volume":"4","author":"Lopes LC","year":"2014","journal-title":"BMJ Open"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/1076029611436193","article-title":"Usefulness of thrombophilia testing in venous thromboembolic disease: findings from the RIETE registry","volume":"19","author":"Gabriel F","year":"2013","journal-title":"Clin Appl Thromb Hemost"},{"issue":"1","key":"ref6","first-page":"1","article-title":"Tromboembolismo venoso","author":"Veiga AGM","year":"2014","journal-title":"Rev Bras Med"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1590\/S1677-54492005000300012","article-title":"O papel do mapeamento d\u00faplex no diagn\u00f3stico da trombose venosa profunda assintom\u00e1tica dos membros inferiores","volume":"4","author":"Giannini M","year":"2005","journal-title":"J Vasc Bras"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"g1340","DOI":"10.1136\/bmj.g1340","article-title":"Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups : individual patient data meta-analysis","volume":"348","author":"Geersing GJ","year":"2014","journal-title":"BMJ"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1370\/afm.648","article-title":"Review of the evidence on diagnosis of deep venous thrombosis and pulmonary embolism","volume":"5","author":"Segal JB","year":"2007","journal-title":"Ann Fam Med"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.295.2.199","article-title":"Does this patient have deep vein thrombosis?","volume":"295","author":"Wells P","year":"2006","journal-title":"JAMA"},{"issue":"9","key":"ref11","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/bloodadvances.2020001755","article-title":"A user guide to the American Society of Hematology clinical practice guidelines","volume":"4","author":"Izcovich A","year":"2020","journal-title":"Blood Adv"},{"issue":"8961","key":"ref12","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/S0140-6736(95)92535-X","article-title":"Accuracy of clinical assessment of deep-vein thrombosis","volume":"345","author":"Wells P","year":"1995","journal-title":"Lancet"},{"key":"ref13","series-title":"Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing","year":"2012"},{"issue":"19","key":"ref14","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.jacc.2017.09.024","article-title":"A test in context: D-dimer","volume":"70","author":"Weitz JI","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.annemergmed.2013.12.018","article-title":"Clinical utility of an age-adjusted D-dimer in the diagnosis of venous thromboembolism","volume":"64","author":"Adams D","year":"2014","journal-title":"Ann Emerg Med"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejogrb.2009.09.005","article-title":"The use of D-dimer with new cutoff can be useful in diagnosis of venous thromboembolism in pregnancy","volume":"148","author":"Kovac M","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/jth.12515","article-title":"D-dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial","volume":"12","author":"Cohen AT","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1182\/blood-2002-05-1416","article-title":"Fibrin fragment d-dimer and the risk of future venous thrombosis","volume":"101","author":"Cushman M","year":"2003","journal-title":"Blood"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/MBC.0b013e32831bc2de","article-title":"d-Dimer before chemotherapy might predict venous thromboembolism","volume":"20","author":"Arpaia G","year":"2009","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"25","key":"ref20","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.21.7752","article-title":"D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study","volume":"27","author":"Ay C","year":"2009","journal-title":"J Clin Oncol"},{"issue":"8","key":"ref21","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/annonc\/mdq012","article-title":"d-Dimer level as a risk factor for postoperative venous thromboembolism in Japanese women with gynecologic cancer","volume":"21","author":"Kodama J","year":"2010","journal-title":"Ann Oncol"},{"issue":"7","key":"ref22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.7326\/0003-4819-149-7-200810070-00008","article-title":"Systematic review: d-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism","volume":"149","author":"Verhovsek M","year":"2008","journal-title":"Ann Intern Med"},{"issue":"8","key":"ref23","doi-asserted-by":"crossref","first-page":"523","DOI":"10.7326\/0003-4819-153-8-201010190-00009","article-title":"Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of d-dimer testing to assess recurrence risk after unprovoked venous thromboembolism","volume":"153","author":"Douketis J","year":"2010","journal-title":"Ann Intern Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.thromres.2020.11.015","article-title":"D-dimer levels over time after anticoagulation and the association with recurrent venous thromboembolism","volume":"197","author":"Steinbrecher O","year":"2021","journal-title":"Thromb Res"},{"issue":"12","key":"ref25","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/jamainternmed.2021.6203","article-title":"Efficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with COVID-19: the HEP-COVID randomized clinical trial","volume":"181","author":"Spyropoulos AC","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3390\/jcm9061651","article-title":"COVID-19 related coagulopathy: a distinct entity?","volume":"9","author":"Marchandot B","year":"2020","journal-title":"J Clin Med"},{"key":"ref27","article-title":"Associations of D-dimer on admission and clinical features of COVID-19 patients: a systematic review, meta-analysis, and meta-regression","volume":"12","author":"Zhao R","year":"2021","journal-title":"Front Immunol"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/bmjebm-2020-111536","article-title":"Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis","volume":"26","author":"Malik P","year":"2021","journal-title":"BMJ Evid Based Med"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/jth.14859","article-title":"D-Dimer levels on admission to predict in-hospital mortality in patients with Covid-19","volume":"18","author":"Zhang L","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.surg.2019.05.030","article-title":"Comparison of the recanalization rate and postthrombotic syndrome in patients with deep venous thrombosis treated with rivaroxaban or warfarin","volume":"166","author":"Athayde Soares R","year":"2019","journal-title":"Surgery"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jvsv.2015.07.008","article-title":"Relationship between development of post-thrombotic syndrome and serial ultrasound, D-dimer, and factor VIII activity after a first deep venous thrombosis","volume":"4","author":"Roberts LN","year":"2016","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1370\/afm.667","article-title":"Current diagnosis of venous thrombo- embolism in primary care: a clinical practice guideline from the American Academy of Family Physicians and the","volume":"5","author":"Qaseem A","year":"2007","journal-title":"Ann Fam Med"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/archinte.162.4.401","article-title":"Sensitivity and specificity of ultrasonography in the diagnosis of upper extremity deep vein thrombosis: a systematic review","volume":"162","author":"Mustafa BO","year":"2002","journal-title":"Arch Intern Med"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1160\/TH12-07-0473","article-title":"Accuracy of emergency physician-performed ultrasonography in the diagnosis of deep-vein thrombosis: a systematic review and meta-analysis","volume":"109","author":"Pomero F","year":"2013","journal-title":"Thromb Haemost"},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/jcu.20236","article-title":"Current approaches and controversial issues in the diagnosis of deep vein thrombosis via duplex Doppler ultrasound","volume":"34","author":"Gaitini D","year":"2006","journal-title":"J Clin Ultrasound"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/jth.12124","article-title":"Diagnostic management of acute deep vein thrombosis and pulmonary embolism","volume":"11","author":"Huisman M","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1538-7836.2007.02328.x","article-title":"Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review","volume":"5","author":"Di Nisio M","year":"2007","journal-title":"J Thromb Haemost"},{"key":"ref38","series-title":"Rutherford\u2019s vascular surgery and endovascular therapy. 2- volume set.","author":"Sidawy AP","year":"2022"},{"issue":"14","key":"ref39","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/CIRCULATIONAHA.117.030687","article-title":"Ultrasound for lower extremity deep venous thrombosis: multidisciplinary recommendations from the Society of Radiologists in Ultrasound Consensus Conference","volume":"137","author":"Needleman L","year":"2018","journal-title":"Circulation"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.avsg.2016.05.113","article-title":"Clinical role of the \u201cvenous\u201d ultrasound to identify lower extremity pathology","volume":"38","author":"Aurshina A","year":"2017","journal-title":"Ann Vasc Surg"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11239-006-5207-3","article-title":"Doppler ultrasonography versus venography in the detection of deep vein thrombosis in patients with pulmonary embolism","volume":"21","author":"Ozbudak O","year":"2006","journal-title":"J Thromb Thrombolysis"},{"issue":"3","key":"ref42","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.crad.2007.09.010","article-title":"Diagnostic value of CT for deep vein thrombosis : results of a systematic review and meta-analysis","volume":"63","author":"Thomas SM","year":"2008","journal-title":"Clin Radiol"},{"issue":"9","key":"ref43","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/MNM.0b013e32834774c8","article-title":"18F-FDG PET-CT in the diagnosis of tumor thrombus: can it be differentiated from benign thrombus?","volume":"32","author":"Sharma P","year":"2011","journal-title":"Nucl Med Commun"},{"issue":"5","key":"ref44","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1067\/mva.2001.118803","article-title":"Computed tomo- graphic venography is specific but not sensitive for diagnosis of acute lower-extremity deep venous thrombosis in patients with suspected pulmonary embolus","volume":"34","author":"Peterson DA","year":"2001","journal-title":"J Vasc Surg"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00330-006-0178-5","article-title":"The accuracy of MRI in diagnosis of suspected deep vein thrombosis: systematic review and meta-analysis","volume":"17","author":"Sampson FC","year":"2007","journal-title":"Eur Radiol"},{"issue":"14","key":"ref46","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.300.14.1653","article-title":"Serial 2-point ultrasonography plus D-dimer vs whole-leg color-coded Doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis: a randomized controlled trial","volume":"300","author":"Bernardi E","year":"2008","journal-title":"JAMA"},{"key":"ref47","series-title":"Rutherford\u2019s vascular surgery and endovascular therapy. 2- volume set.","author":"Sidawy AP","year":"2022"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11239-015-1317-0","article-title":"Guidance for the treatment of deep vein thrombosis and pulmonary embolism","volume":"41","author":"Streiff MB","year":"2016","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1182\/asheducation-2016.1.413","article-title":"The post-thrombotic syndrome","volume":"2016","author":"Kahn SR","year":"2016","journal-title":"Hematology"},{"issue":"23","key":"ref50","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa1615066","article-title":"Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis","volume":"377","author":"Vedantham S","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"ref51","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Kearon C","year":"2012","journal-title":"Chest"},{"issue":"11","key":"ref52","doi-asserted-by":"crossref","first-page":"516","DOI":"10.5694\/mja2.50201","article-title":"Deep vein thrombosis: update on diagnosis and management","volume":"210","author":"Kruger PC","year":"2019","journal-title":"Med J Aust"},{"issue":"2","key":"ref53","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/1076029612474840","article-title":"Prevention and treatment of venous thromboembolism: international consensus statement (guidelines according to scientific evidence)","volume":"19","author":"Othieno R","year":"2013","journal-title":"Clin Appl Thromb Hemost"},{"issue":"6","key":"ref54","doi-asserted-by":"crossref","first-page":"454S","DOI":"10.1378\/chest.08-0658","article-title":"Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)","volume":"133","author":"Kearon C","year":"2008","journal-title":"Chest"},{"issue":"7","key":"ref55","doi-asserted-by":"crossref","first-page":"636","DOI":"10.2174\/1389200218666170518165443","article-title":"Rivaroxaban \u2013 metabolism, pharmacologic properties and drug interactions","volume":"18","author":"Kvasnicka T","year":"2017","journal-title":"Curr Drug Metab"},{"issue":"2","key":"ref56","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1590\/S1806-37562016042020068","article-title":"New anticoagulants for the treatment of venous thromboembolism","volume":"42","author":"Santos FCJC","year":"2016","journal-title":"J Bras Pneumol"},{"issue":"7","key":"ref57","doi-asserted-by":"crossref","first-page":"636","DOI":"10.2174\/1389200218666170518165443","article-title":"Rivaroxaban: metabolism, pharmacologic properties and drug interactions","volume":"18","author":"Kvasnicka T","year":"2017","journal-title":"Curr Drug Metab"},{"issue":"1","key":"ref58","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.clinthera.2012.12.005","article-title":"Rivaroxaban: an oral factor Xa inhibitor","volume":"35","author":"Thomas TF","year":"2013","journal-title":"Clin Ther"},{"issue":"10","key":"ref59","article-title":"Diretrizes internacionais de pr\u00e1tica cl\u00ednica de 2019 para o tratamento e profilaxia de doen\u00e7as venosas tromboembolismo em pacientes com c\u00e2ncer","volume":"20","author":"Farge D","year":"2019","journal-title":"Lancet Oncol"},{"issue":"4","key":"ref60","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1590\/1677-5449.080916","article-title":"Anticoagulantes orais diretos no tratamento do tromboembolismo venoso em pacientes com c\u00e2ncer","volume":"15","author":"Yoshida WB","year":"2016","journal-title":"J Vasc Bras"},{"issue":"26","key":"ref61","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"Bauersachs R","year":"2010","journal-title":"N Engl J Med"},{"issue":"14","key":"ref62","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1113572","article-title":"Oral rivaroxaban for the treatment of symptomatic pulmonary embolism","volume":"366","author":"B\u00fcller HR","year":"2012","journal-title":"N Engl J Med"},{"key":"ref63","series-title":"First market approval in Japan for LIXIANA (Edoxaban).","year":"2011"},{"key":"ref64","series-title":"FDA approves edoxaban for stroke prevention in AF and DVT\/PE prevention.","author":"O\u2019Riordan M.","year":"2015"},{"issue":"11","key":"ref65","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/jcph.540","article-title":"Evaluation of regional gastrointestinal absorption of edoxaban using the enterion capsule","volume":"55","author":"Parasrampuria DA","year":"2015","journal-title":"J Clin Pharmacol"},{"key":"ref66","series-title":"Savaysa (edoxaban) tablets","year":"2019"},{"issue":"5","key":"ref67","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1177\/0091270010370974","article-title":"Effects of food on the pharmacokinetics of edoxaban, an oral direct factor Xa inhibitor, in healthy volunteers","volume":"51","author":"Mendell J","year":"2011","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"ref68","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.amjmed.2016.12.033","article-title":"Oral anticoagulant use after bariatric surgery: a literature review and clinical guidance","volume":"130","author":"Martin KA","year":"2017","journal-title":"Am J Med"},{"issue":"9","key":"ref69","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1111\/j.1538-7836.2008.03064.x","article-title":"DU-176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles","volume":"6","author":"Furugohri T","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"7","key":"ref70","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/0091270009351883","article-title":"Clinical safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel factor Xa inhibitor edoxaban in healthy volunteers","volume":"50","author":"Ogata K","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.thromres.2017.12.005","article-title":"Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edox- aban for the treatment of venous thromboembolism: an analysis of the randomized, double-blind Hokusai-VTE trial","volume":"162","author":"Vanassche T","year":"2018","journal-title":"Thromb Res"},{"issue":"10","key":"ref72","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1253\/circj.CJ-19-0535","article-title":"Efficacy and safety of uninterrupted periprocedural edoxaban in patients undergoing catheter ablation for atrial fibrillation: the prospective KYU-RABLE study","volume":"83","author":"Takahashi N","year":"2019","journal-title":"Circ J"},{"issue":"6","key":"ref73","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1253\/circj.CJ-18-1362","article-title":"Safety and effectiveness of edoxaban in Japanese patients with venous thromboembolism: an interim analysis of data from a Japanese postmarketing observational study (ETNA-VTE-Japan)","volume":"83","author":"Nakamura M","year":"2019","journal-title":"Circ J"},{"issue":"15","key":"ref74","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1306638","article-title":"Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism","volume":"369","author":"B\u00fcller HR","year":"2013","journal-title":"N Engl J Med"},{"issue":"8","key":"ref75","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1055\/s-0036-1598004","article-title":"Anticoagulation therapy in children","volume":"43","author":"Radulescu VC","year":"2017","journal-title":"Semin Thromb Hemost"},{"issue":"24","key":"ref76","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1182\/blood-2015-06-651539","article-title":"Improving evidence on anticoagulant therapies for venous thromboembolism in children: key challenges and opportunities","volume":"126","author":"Goldenberg NA","year":"2015","journal-title":"Blood"},{"issue":"15","key":"ref77","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1306638","article-title":"Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism","volume":"369","author":"B\u00fcller HR","year":"2013","journal-title":"N Engl J Med"},{"issue":"2","key":"ref78","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jjcc.2018.03.006","article-title":"Comparison of the effects of edoxaban, an oral direct factor Xa inhibitor, on venous throm- boembolism between patients with and without cancer","volume":"72","author":"Ikeda S","year":"2018","journal-title":"J Cardiol"},{"issue":"4","key":"ref79","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3400\/avd.oa.17-00054","article-title":"Assessment of the safety and efficacy of edoxaban for the treatment of venous thromboembolism secondary to active malignancy","volume":"10","author":"Hara N","year":"2017","journal-title":"Ann Vasc Dis"},{"issue":"6","key":"ref80","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1080\/17453674.2017.1361131","article-title":"Comparative efficacy and safety of anticoagulants for prevention of venous thromboembolism after hip and knee arthroplasty","volume":"88","author":"Hur M","year":"2017","journal-title":"Acta Orthop"},{"issue":"2","key":"ref81","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.arth.2016.09.033","article-title":"safety and efficacy of new anticoagulants for the prevention of venous thromboembolism after hip and knee arthroplasty: a meta-analysis","volume":"32","author":"Venker BT","year":"2017","journal-title":"J Arthroplasty"},{"issue":"1","key":"ref82","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12959-016-0121-1","article-title":"Edoxaban versus enoxaparin for the prevention of venous thromboembolism after total knee or hip arthroplasty: pooled analysis of coagulation biomarkers and primary efficacy and safety endpoints from two phase 3 trials","volume":"14","author":"Kawai Y","year":"2016","journal-title":"Thromb J"},{"issue":"8","key":"ref83","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/j.1538-7836.2008.03054.x","article-title":"Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis","volume":"6","author":"Buller H","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"2","key":"ref84","doi-asserted-by":"crossref","first-page":"e531S","DOI":"10.1378\/chest.11-2304","article-title":"Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9. ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"You JJ","year":"2012","journal-title":"Chest"},{"issue":"2","key":"ref85","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.11-2404","article-title":"Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Falck-Ytter Y","year":"2012","journal-title":"Chest"},{"key":"ref86","first-page":"19","article-title":"Assessment of the sites of gastrointestinal absorption of apixaban in healthy subjects","volume":"2","author":"Frost C","year":"2013","journal-title":"Clin Pharmacol Drug Dev"},{"key":"ref87","series-title":"Eliquis (apixaban) tablets","year":"2019"},{"issue":"3","key":"ref88","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s13318-011-0037-x","article-title":"Preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitor","volume":"36","author":"He K","year":"2011","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"ref89","doi-asserted-by":"crossref","DOI":"10.1177\/1076029619849103","article-title":"Cost-effectiveness evaluations among the direct oral anticoagulants for the prevention and treatment of venous thromboembolism: systematic review","volume":"25","author":"Al Mukdad M","year":"2019","journal-title":"Clin Appl Thromb Hemost"},{"issue":"10","key":"ref90","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/europace\/eus305","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation:an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association","volume":"14","author":"Camm AJ","year":"2012","journal-title":"Europace"},{"issue":"10","key":"ref91","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1345\/aph.1Q119","article-title":"The role of apixaban for venous and arterial thromboembolic disease","volume":"45","author":"Prom R","year":"2011","journal-title":"Ann Pharmacother"},{"issue":"9","key":"ref92","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1302507","article-title":"Oral apixaban for the treatment of acute venous thromboembolism","volume":"369","author":"Agnelli G","year":"2013","journal-title":"N Engl J Med"},{"issue":"9","key":"ref93","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1056\/NEJMe1307413","article-title":"Treating acute venous thromboembolism: shift with care","volume":"369","author":"Cushman M","year":"2013","journal-title":"N Engl J Med"},{"issue":"8","key":"ref94","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1207541","article-title":"Apixaban for extended treatment of venous thromboembolism","volume":"368","author":"Agnelli G","year":"2013","journal-title":"N Engl J Med"},{"issue":"8","key":"ref95","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJMe1215678","article-title":"Extended treatment of venous thromboembolism","volume":"368","author":"Connors JM","year":"2013","journal-title":"N Engl J Med"},{"issue":"11","key":"ref96","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger CB","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"ref97","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ahj.2009.07.035","article-title":"Apixaban for reduction in stroke and other thromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale","volume":"159","author":"Lopes RD","year":"2010","journal-title":"Am Heart J"},{"issue":"11","key":"ref98","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1111\/j.1538-7836.2007.02748.x","article-title":"Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial","volume":"5","author":"Eriksson BI","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"3","key":"ref99","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1124\/dmd.109.029694","article-title":"In vitro assessment of metabolic drug-drug interaction potential of apixaban through cytochrome P450 phenotyping, inhibition, and induction studies","volume":"38","author":"Wang L","year":"2010","journal-title":"Drug Metab Dispos"},{"issue":"24","key":"ref100","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa0906598","article-title":"Dabigatran versus warfarin in the treatment of acute venous thromboembolism","volume":"361","author":"Schulman S","year":"2009","journal-title":"N Engl J Med"},{"key":"ref101","series-title":"Pradaxa","year":"2023"},{"issue":"7","key":"ref102","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/CIRCULATIONAHA.113.004450","article-title":"Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis","volume":"129","author":"Schulman S","year":"2014","journal-title":"Circulation"},{"issue":"19","key":"ref103","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1001\/archinternmed.2010.367","article-title":"Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review","volume":"170","author":"Iorio A","year":"2010","journal-title":"Arch Intern Med"},{"issue":"2","key":"ref104","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3324\/haematol.10516","article-title":"The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients","volume":"92","author":"Prandoni P","year":"2007","journal-title":"Haematologica"},{"issue":"6","key":"ref105","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199702063360601","article-title":"The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group","volume":"336","author":"Schulman S","year":"1997","journal-title":"N Engl J Med"},{"issue":"7","key":"ref106","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1182\/bloodadvances.2018017160","article-title":"Risk of recurrent venous thromboembolism according to baseline risk factor profiles","volume":"2","author":"Prins MH","year":"2018","journal-title":"Blood Adv"},{"issue":"1","key":"ref107","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jama.2015.7046","article-title":"Six months vs extended oral anticoagulation after a first episode of pulmonary embolism: the PADIS-PE randomized clinical trial","volume":"314","author":"Couturaud F","year":"2015","journal-title":"JAMA"},{"issue":"15","key":"ref108","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa035029","article-title":"Long-term, low- intensity warfarin therapy for the prevention of recurrent venous thromboembolism","volume":"348","author":"Ridker PM","year":"2003","journal-title":"N Engl J Med"},{"issue":"8","key":"ref109","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa1113697","article-title":"Extended use of dabigatran, warfarin, or placebo in venous thromboembolism","volume":"368","author":"Schulman S","year":"2013","journal-title":"N Engl J Med"},{"issue":"26","key":"ref110","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"Bauersachs R","year":"2010","journal-title":"N Engl J Med"},{"issue":"13","key":"ref111","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJMoa1700518","article-title":"Rivaroxaban or aspirin for extended treatment of venous thromboembolism","volume":"376","author":"Weitz JI","year":"2017","journal-title":"N Engl J Med"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.thromres.2020.09.001","article-title":"ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 months","volume":"196","author":"Agnelli G","year":"2020","journal-title":"Thromb Res"},{"issue":"4","key":"ref113","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9343(98)00060-6","article-title":"Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy","volume":"104","author":"Schulman S","year":"1998","journal-title":"Am J Med"},{"key":"ref114","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.thromres.2020.11.036","article-title":"Using oral anticoagulants among chronic kidney disease patients to prevent recurrent venous thromboembolism: a systematic review and meta-analysis","volume":"198","author":"Alhousani M","year":"2021","journal-title":"Thromb Res"},{"key":"ref115","doi-asserted-by":"crossref","DOI":"10.1590\/1677-5449.200109","article-title":"Avalia\u00e7\u00e3o do risco de sangramento na profilaxia do tromboembolismo venoso","volume":"20","author":"Chindamo MC","year":"2021","journal-title":"J Vasc Bras"},{"issue":"1","key":"ref116","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2020.09.023","article-title":"European Society for Vascular Surgery (ESVS) 2021 clinical practice guidelines on the management of venous thrombosis","volume":"61","author":"Kakkos SK","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"6","key":"ref117","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1177\/10600280211040093","article-title":"A review of direct oral anticoagulants in patients with stage 5 or end-stage kidney disease","volume":"56","author":"Starr JA","year":"2022","journal-title":"Ann Pharmacother"},{"issue":"22","key":"ref118","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1182\/bloodadvances.2018024893","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy","volume":"2","author":"Witt DM","year":"2018","journal-title":"Blood Adv"},{"issue":"4","key":"ref119","article-title":"Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis","volume":"4","author":"Wang X","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"ref120","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1590\/1677-5449.006616","article-title":"Profilaxia de tromboembolismo venoso na gesta\u00e7\u00e3o","volume":"15","author":"Oliveira ALML","year":"2016","journal-title":"J Vasc Bras"},{"key":"ref121","series-title":"Tromboembolismo venoso na gesta\u00e7\u00e3o: protocolos FEBRASGO.","year":"2018"},{"issue":"2","key":"ref122","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/bdra.23435","article-title":"Low-dose maternal warfarin intake resulting in fetal warfarin syndrome: In search for a safe anticoagulant regimen during pregnancy","volume":"106","author":"Basu S","year":"2016","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"ref123","article-title":"Tromboembolismo venoso na mulher: novos desafios para uma velha doen\u00e7a","volume":"19","author":"Oliveira ALML","year":"2020","journal-title":"J Vasc Bras"},{"key":"ref124","series-title":"Preven\u00e7\u00e3o do tromboembolismo na gestante hospitalizada e no puerp\u00e9rio.","year":"2021"},{"key":"ref125","article-title":"Venous thromboembolism in transgender women","volume":"21","author":"Marques MA","year":"2023","journal-title":"J Vasc Bras"},{"issue":"2","key":"ref126","doi-asserted-by":"crossref","first-page":"d3036","DOI":"10.1136\/bmj.d3036","article-title":"Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants\u2019 data from seven trials","volume":"342","author":"Boutitie F","year":"2011","journal-title":"BMJ"},{"issue":"1","key":"ref127","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7326\/0003-4819-139-1-200307010-00008","article-title":"Extended oral anticoagulant therapy after a first episode of pulmonary embolism","volume":"139","author":"Agnelli G","year":"2003","journal-title":"Ann Intern Med"},{"issue":"4","key":"ref128","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"Konstantinides SV","year":"2020","journal-title":"Eur Heart J"},{"issue":"21","key":"ref129","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJMoa1210384","article-title":"Low-dose aspirin for preventing recurrent venous thromboembolism","volume":"367","author":"Brighton TA","year":"2012","journal-title":"N Engl J Med"},{"issue":"21","key":"ref130","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa1114238","article-title":"Aspirin for preventing the recurrence of venous thromboembolism","volume":"366","author":"Becattini C","year":"2012","journal-title":"N Engl J Med"},{"issue":"8","key":"ref131","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1207541","article-title":"Apixaban for extended treatment of venous thromboembolism","volume":"368","author":"Agnelli G","year":"2013","journal-title":"N Engl J Med"},{"issue":"7","key":"ref132","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1160\/TH17-01-0065","article-title":"NOACs for treatment of venous thromboembolism in clinical practice","volume":"117","author":"Schulman S","year":"2017","journal-title":"Thromb Haemost"},{"issue":"2","key":"ref133","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11239-021-02463-x","article-title":"Safety and effectiveness of dabigatran in routine clinical practice: the RE-COVERY DVT\/PE study","volume":"53","author":"Goldhaber SZ","year":"2022","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"ref134","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1055\/s-0041-1729169","article-title":"Profile of patients with isolated distal deep vein thrombosis versus proximal deep vein thrombosis or pulmonary embolism: RE-COVERY DVT\/PE study","volume":"48","author":"Schellong S","year":"2022","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"ref135","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s11239-020-02239-9","article-title":"Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT\/PE study","volume":"51","author":"Ageno W","year":"2021","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"ref136","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1016\/S2352-3026(15)00257-4","article-title":"Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study","volume":"3","author":"Ageno W","year":"2016","journal-title":"Lancet Haematol"},{"issue":"4","key":"ref137","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/bcp.12391","article-title":"Safety of switching from vitamin K antagonists to dabigatran or rivaroxaban in daily care--results from the Dresden NOAC registry","volume":"78","author":"Beyer-Westendorf J","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"ref138","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1182\/blood-2014-03-563577","article-title":"Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry","volume":"124","author":"Beyer-Westendorf J","year":"2014","journal-title":"Blood"},{"issue":"3","key":"ref139","first-page":"472","article-title":"Rivaroxaban for the treatment of venous thromboembolism. The SWIss Venous ThromboEmbolism Registry (SWIVTER)","volume":"116","author":"Kucher N","year":"2016","journal-title":"Thromb Haemost"},{"key":"ref140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.thromres.2022.11.016","article-title":"36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE","volume":"222","author":"Turpie AGG","year":"2023","journal-title":"Thromb Res"},{"issue":"2","key":"ref141","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1055\/s-0038-1676611","article-title":"Characteristics and management of patients with venous thromboembolism: the GARFIELD-VTE registry","volume":"119","author":"Ageno W","year":"2019","journal-title":"Thromb Haemost"},{"issue":"13","key":"ref142","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood-2018-04-848333","article-title":"Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome","volume":"132","author":"Pengo V","year":"2018","journal-title":"Blood"},{"issue":"6","key":"ref143","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1007\/s00270-012-0342-z","article-title":"Role of IVC filters in endovenous therapy for deep venous thrombosis: the FILTER-PEVI (Filter Implantation to Lower Thromboembolic Risk in Percutaneous Endovenous Intervention) trial","volume":"35","author":"Sharifi M","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"1","key":"ref144","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/jth.13564","article-title":"Infenor vena cava filters","volume":"15","author":"Duffett L","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"3","key":"ref145","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/CIRCULATIONAHA.104.512834","article-title":"Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d\u2019Embolie Pulmonaire par Interruption Cave) randomized study","volume":"112","year":"2005","journal-title":"Circulation"},{"issue":"16","key":"ref146","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1001\/jama.2015.3780","article-title":"Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism a randomized clinical trial","volume":"313","author":"Mismetti P","year":"2015","journal-title":"JAMA"},{"issue":"9810","key":"ref147","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(11)61753-4","article-title":"Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial","volume":"379","author":"Enden T","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"ref148","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1016\/S2352-3026(15)00248-3","article-title":"Post-thrombotic syndrome after catheter-directed throm- bolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial","volume":"3","author":"Haig Y","year":"2016","journal-title":"Lancet Haematol"},{"issue":"8","key":"ref149","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-002984","article-title":"Health-related quality of life after catheter-directed thrombolysis for deep vein thrombosis: secondary outcomes of the rando- mised, non-blinded, parallel-group CaVenT study","volume":"3","author":"Enden T","year":"2013","journal-title":"BMJ Open"},{"issue":"6","key":"ref150","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/jth.12184","article-title":"Cost- effectiveness of additional catheter-directed thrombolysis for deep vein thrombosis","volume":"11","author":"Enden T","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"23","key":"ref151","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa1615066","article-title":"Pharmacomechanical catheter-directed thrombol- ysis for deep-vein thrombosis","volume":"377","author":"Vedantham S","year":"2017","journal-title":"N Engl J Med"},{"issue":"9","key":"ref152","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.jvir.2021.06.001","article-title":"Clinical outcomes of a pharmacomechanical catheter-directed venous thrombolysis strategy that included rheolytic thrombectomy in a multicenter randomized trial","volume":"32","author":"Vedantham S","year":"2021","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"ref153","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1016\/S2352-3026(19)30209-1","article-title":"Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post- thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial","volume":"7","author":"Notten P","year":"2020","journal-title":"Lancet Haematol"},{"issue":"9","key":"ref154","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1161\/CIRCULATIONAHA.118.037425","article-title":"Endovascular thrombus removal for acute ilio- femoral deep vein thrombosis","volume":"139","author":"Comerota AJ","year":"2019","journal-title":"Circulation"},{"issue":"4","key":"ref155","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1055\/s-0039-1677795","article-title":"Pharmacomechanical catheter-directed thrombolysis in acute femoral-popliteal deep vein thrombosis: analysis from a stratified randomized trial","volume":"119","author":"Kearon C","year":"2019","journal-title":"Thromb Haemost"},{"issue":"1","key":"ref156","article-title":"Thrombolytic strategies versus standard anticoagulation for acute deep vein thrombosis of the lower limb","volume":"1","author":"Broderick C","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"ref157","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1016\/j.mayocp.2020.08.030","article-title":"Anticoagulation in COVID-19: a systematic review, meta-analysis, and rapid guidance from Mayo Clinic","volume":"95","author":"McBane 2nd RD","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"ref158","article-title":"Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: a systematic review and meta-analysis","volume":"29","author":"Malas MB","year":"2020","journal-title":"EClinicalMedicine"},{"key":"ref159","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.thromres.2020.08.022","article-title":"Incidence of venous and arterial thromboembolic complications in COVID-19: A systematic review and meta-analysis","volume":"196","author":"Kunutsor SK","year":"2020","journal-title":"Thromb Res"},{"issue":"4","key":"ref160","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/1358863X21995566","article-title":"Venous thromboembolism in COVID-19: a systematic review and meta-analysis","volume":"26","author":"Kollias A","year":"2021","journal-title":"Vasc Med"},{"issue":"2","key":"ref161","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1097\/CCM.0b013e3181c9e344","article-title":"Thromboprophylaxis in the intensive care unit: focus on medical\u2013surgical patients","volume":"38","author":"Cook DJ","year":"2010","journal-title":"Crit Care Med"},{"issue":"9","key":"ref162","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/archinte.164.9.963","article-title":"Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX study","volume":"164","author":"Alikhan R","year":"2004","journal-title":"Arch Intern Med"},{"issue":"11","key":"ref163","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199909093411103","article-title":"A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients","volume":"341","author":"Samama MM","year":"1999","journal-title":"N Engl J Med"},{"issue":"2","key":"ref164","doi-asserted-by":"crossref","first-page":"E70","DOI":"10.1148\/radiol.2020203557","article-title":"Pulmonary embolism and deep vein thrombosis in COVID-19: a systematic review and meta-analysis","volume":"298","author":"Suh YJ","year":"2021","journal-title":"Radiology"},{"issue":"2","key":"ref165","doi-asserted-by":"crossref","first-page":"e351S","DOI":"10.1378\/chest.11-2299","article-title":"Diagnosis of DVT: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Bates SM","year":"2012","journal-title":"Chest"},{"issue":"10223","key":"ref166","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang C","year":"2020","journal-title":"Lancet"},{"key":"ref167","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.thromres.2020.05.018","article-title":"Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels","volume":"192","author":"Demelo-Rodr\u00edguez P","year":"2020","journal-title":"Thromb Res"},{"key":"ref168","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3389\/fpubh.2020.00432","article-title":"D-dimer concentrations and COVID-19 severity: a systematic review and meta-analysis","volume":"8","author":"Paliogiannis P","year":"2020","journal-title":"Front Public Health"},{"key":"ref169","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ijid.2020.09.021","article-title":"Meta-analysis of coagulation parameters associated with disease severity and poor prognosis of COVID-19","volume":"100","author":"Zhang A","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"6","key":"ref170","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/jcu.20236","article-title":"Current approaches and controversial issues in the diagnosis of deep vein thrombosis via duplex Doppler ultrasound","volume":"34","author":"Gaitini D","year":"2006","journal-title":"J Clin Ultrasound"},{"issue":"2","key":"ref171","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","volume":"149","author":"Kearon C","year":"2016","journal-title":"Chest"},{"issue":"9","key":"ref172","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa2103417","article-title":"Therapeutic anticoagulation with heparin in critically Ill patients with Covid-19","volume":"385","author":"Goligher EC","year":"2021","journal-title":"N Engl J Med"},{"issue":"9","key":"ref173","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa2105911","article-title":"Therapeutic anticoagulation with heparin in Noncritically Ill patients with Covid-19","volume":"385","author":"Lawler PR","year":"2021","journal-title":"N Engl J Med"},{"issue":"16","key":"ref174","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1001\/jama.2021.4152","article-title":"Effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with COVID-19 admitted to the Intensive Care Unit: the INSPIRATION Randomized Clinical Trial","volume":"325","author":"Sadeghipour P","year":"2021","journal-title":"JAMA"},{"key":"ref175","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.thromres.2020.09.026","article-title":"Therapeutic versus prophylactic anticoagulation for severe COVID-19: a randomized phase II clinical trial (HESACOVID)","volume":"196","author":"Lemos ACB","year":"2020","journal-title":"Thromb Res"},{"issue":"3","key":"ref176","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.chest.2020.11.005","article-title":"Incidence of VTE and bleeding among hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis","volume":"159","author":"Jim\u00e9nez D","year":"2021","journal-title":"Chest"},{"issue":"20","key":"ref177","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1182\/blood.2020010529","article-title":"Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry","volume":"137","author":"Giannis D","year":"2021","journal-title":"Blood"},{"issue":"10319","key":"ref178","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0140-6736(21)02392-8","article-title":"Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial","volume":"399","author":"Ramacciotti E","year":"2022","journal-title":"Lancet"}],"container-title":["Jornal Vascular Brasileiro"],"original-title":["Diretrizes sobre trombose venosa profunda da Sociedade Brasileira de Angiologia e Cirurgia Vascular"],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S1677-54492024000101103&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T17:12:05Z","timestamp":1728493925000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1677-54492024000101103&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":178,"alternative-id":["S1677-54492024000101103"],"URL":"https:\/\/doi.org\/10.1590\/1677-5449.202301072","relation":{"has-translation":[{"id-type":"doi","id":"10.1590\/1677-5449.202301071","asserted-by":"subject"}]},"ISSN":["1677-7301","1677-5449"],"issn-type":[{"value":"1677-7301","type":"electronic"},{"value":"1677-5449","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e20230107"}}